Edwards Lifesciences CorporationEWNYSE
Loading
Income Before Tax Over TimeContracting
Percentile Rank71
3Y CAGR-10.4%
5Y CAGR+6.8%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
-10.4%/yr
vs +23.4%/yr prior
5Y CAGR
+6.8%/yr
Recent deceleration
Acceleration
-33.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.27B | -17.8% |
| 2024 | $1.55B | +12.8% |
| 2023 | $1.37B | -22.3% |
| 2022 | $1.77B | +3.8% |
| 2021 | $1.70B | +85.7% |
| 2020 | $916.70M | -21.4% |
| 2019 | $1.17B | +53.2% |
| 2018 | $761.40M | -26.4% |
| 2017 | $1.03B | +40.2% |
| 2016 | $737.90M | - |